113 results
Page 3 of 6
8-K
EX-99.1
u5mcva71
23 Mar 21
Other Events
8:21am
8-K
EX-99.1
hp9mpyf7j uubrlk
17 Feb 21
Hepion Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock
8:06am
424B5
l7f9kqq pay3cg2h8e
16 Feb 21
Prospectus supplement for primary offering
5:11pm
424B5
uq2z9a4pm9es9paj2n
16 Feb 21
Prospectus supplement for primary offering
6:03am
8-K
EX-99.2
wdd83
10 Feb 21
Hepion Pharmaceuticals to Participate in BIO CEO & Investor Digital Conference
9:03am
S-8
4zb8vd7n9z1zy
19 Jan 21
Registration of securities for employees
12:00am
8-K
EX-99.1
ge4x1
22 Dec 20
Hepion Pharmaceuticals Announces FDA Clearance of IND Application for CRV431 for COVID-19
8:34am
8-K
EX-99.1
2fy8moh
2 Dec 20
Other Events
8:12am
424B4
iv4ugnkoqm1srv
25 Nov 20
Prospectus supplement with pricing info
4:28pm
8-K
EX-99.1
czng1vnj95s53
5 Oct 20
Announces Creation of Clinical Pharmacology Analytics Team
9:06am
8-K
EX-99.1
mwjgcxv04obg63eea48f
7 Jul 20
Hepion Pharmaceuticals Announces Preclinical Data Supporting Novel Two-Pronged Approach to Treating COVID-19 with CRV431
8:26am
8-K
EX-99.1
x22yanw3 dxf
10 Jun 20
Hepion Pharmaceuticals Welcomes Industry Veteran and Drug Development Expert, Dr. Peter Wijngaard, to its Board of Directors
5:04pm
8-K
EX-99.1
146p4lc9p7mr1yq1 q9u
3 Oct 19
Hepion Pharmaceuticals Strengthens Management Team with Three Key Promotions
4:20pm